---
figid: PMC3303613__IJCB2012-594681.001
figlink: /pmc/articles/PMC3303613/figure/fig1/
number: Figure 1
caption: Overview of the signaling pathways in the pathogenesis of nasopharyngeal
  carcinoma (NPC). Initiation of upstream signaling proteins in the NPC development
  begins with LMP1. Subsequent induced activity of downstream proteins in several
  pathways such as β-catenin, NF-κB, and AP-1 leads to dysregulation of cell proliferation
  (cdk/cyclin protein), cell transformation (TERT), increase in angiogenesis (IL-8)
  and metastasis (E-cadherin, MMPs), and inhibition of apoptosis (Bcl-2, p53). Green
  arrows and red blunt-end arrows represent up- and downregulation, respectively.
pmcid: PMC3303613
papertitle: 'Nasopharyngeal Carcinoma Signaling Pathway: An Update on Molecular Biomarkers.'
reftext: Warut Tulalamba, et al. Int J Cell Biol. 2012;2012:594681.
pmc_ranked_result_index: '79352'
pathway_score: 0.880695
filename: IJCB2012-594681.001.jpg
figtitle: Signaling pathways in the pathogenesis of nasopharyngeal carcinoma (NPC)
year: '2012'
organisms: Homo sapiens
ndex: e26c38ea-df12-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3303613__IJCB2012-594681.001.html
  '@type': Dataset
  description: Overview of the signaling pathways in the pathogenesis of nasopharyngeal
    carcinoma (NPC). Initiation of upstream signaling proteins in the NPC development
    begins with LMP1. Subsequent induced activity of downstream proteins in several
    pathways such as β-catenin, NF-κB, and AP-1 leads to dysregulation of cell proliferation
    (cdk/cyclin protein), cell transformation (TERT), increase in angiogenesis (IL-8)
    and metastasis (E-cadherin, MMPs), and inhibition of apoptosis (Bcl-2, p53). Green
    arrows and red blunt-end arrows represent up- and downregulation, respectively.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - HRAS
  - ARAF
  - NRAS
  - RAF1
  - AXIN1
  - FOS
  - MAP2K2
  - BRAF
  - SERPINF2
  - TP53
  - ETS1
  - PTEN
  - APC
  - ETS2
  - BIRC5
  - CDH1
  - TMEM115
  - MYC
  - DUSP6
  - MAPK3
  - AKT2
  - AKT1
  - MAPK1
  - CXCL8
  - MAP2K1
  - AKT3
  - CTNNB1
  - POLD1
  - CDK4
  - TOPORS
  - EGFR
  - AXIN2
  - TERT
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Melanoma
  - Noonan syndrome
genes:
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: -Fos
  symbol: FOS
  source: hgnc_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AP-I
  symbol: API
  source: hgnc_alias_symbol
  hgnc_symbol: SERPINF2
  entrez: '5345'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: Ets
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
- word: PIP,PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: Ets
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS2
  entrez: '2114'
- word: Survivin
  symbol: survivin
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC5
  entrez: '332'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: pl6
  symbol: PL6
  source: hgnc_alias_symbol
  hgnc_symbol: TMEM115
  entrez: '11070'
- word: -Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: DUSP6
  symbol: DUSP6
  source: hgnc_symbol
  hgnc_symbol: DUSP6
  entrez: '1848'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Cdc2/CydlinB
  symbol: CDC2
  source: hgnc_alias_symbol
  hgnc_symbol: POLD1
  entrez: '5424'
- word: Cdk4
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: -lun
  symbol: LUN
  source: hgnc_alias_symbol
  hgnc_symbol: TOPORS
  entrez: '10210'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: TERT
  symbol: TERT
  source: hgnc_symbol
  hgnc_symbol: TERT
  entrez: '7015'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Melanoma
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
